Medical Devices News and Research

RSS

Smartphone juggernaut will impact revenues, design strategies, and IP management, say UBM TechInsights

UBM TechInsights today warned the consumer medical device industry that the smartphone juggernaut will impact revenues, design strategies, and intellectual property management for medical devices in the same way it has for many consumer products including cameras, GPS devices and personal media players.

8 Feb 2011

Misonix completes product registrations in major Latin American countries

Misonix, a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced the completion of product registrations in Argentina, Brazil, Colombia and Peru.

8 Feb 2011

Law allowing use of unproven brain devices in "orphan" neuropsychiatric disorders needs to be strengthened: Experts

Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.

7 Feb 2011

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Convergence Medical Devices (CMD) today announced that its co-founder, Dr. Seward Rutkove, Chief of the Division of Neuromuscular Disease at Beth Israel Deaconess Medical Center and Associate Professor of Neurology at Harvard Medical School, received Prize4Life's prestigious award for the discovery of a new biomarker for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease.

7 Feb 2011

Helix Medical to invest over $4M for new manufacturing facility in Costa Rica

Helix Medical, LLC, a global manufacturer for the medical device and healthcare industries, will soon begin construction on a new medical manufacturing facility in Costa Rica. Helix Medical signed a leasing agreement in The Coyol Free Trade Zone and Business Park in Alajuela, Costa Rica, just outside of San Jose. The company will invest more than $4M in the new plant that will soon employ more than 100 people.

7 Feb 2011

Patient need to share medication side effects with health care team: Retired family doctor

"I had a wonderful gentleman patient who had resistant blood pressure," recalls Vicki Koenig, M.D., a retired family doctor in Exmore, VA. "When he came for a blood pressure check on the latest new med and it was great, I was ecstatic. Then he said, 'But I notice my urine's a little dark.' His was one of the first cases of fatal liver complications from this medication."

5 Feb 2011

Free web-based networking solution for health care professionals to be presented at AAD meeting

PPN, a free and web-based networking and collaborative solution for health care professionals, will be presented at the AAD 69th Annual Meeting, February 4-8, 2011, at the Ernest N. Morial Convention Center, in New Orleans, LA.

5 Feb 2011

Microsulis' Microwave Endometrial Ablation platform sold to Hologic

Microsulis Medical Limited announced this week that it has exclusively licensed to Hologic Inc all rights to its microwave technology in the gynecology and female urology fields of use.

From Hologic, Inc. 5 Feb 2011

Roundup: House Republicans plan to advance anti-abortion agenda with action next week; Medical device makers lobby to repeal tax

House Republicans said Thursday that they plan to consider two significant bills next week that would prevent taxpayer-funded abortions. One of the controversial measures was slightly modified after abortion rights supporters lashed out against language that included limits on exemptions for such situations as rape and incest (Adams, 2/3).

4 Feb 2011

More careful regulation of FDA's Humanitarian Device Exemption in psychiatric patients needed

4 Feb 2011

Positive results from Derma Sciences' Phase 2 trial with DSC127 in patients with diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced positive results from its Phase 2 clinical trial with DSC127 in patients with diabetic foot ulcers, including meeting the trial's primary endpoint, the proportion of study ulcers healed by 12 weeks as defined by 100% epithelialized with no drainage, as well as all secondary endpoints measured at this time.

3 Feb 2011

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.

3 Feb 2011

Kensey Nash second quarter revenue decreases to $17.4 million

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its second quarter ended December 31, 2010.

1 Feb 2011

Covidien first-quarter net sales increase 5% to $2.77 billion

Covidien plc today reported results for the first quarter of fiscal 2011 (October-December 2010). First-quarter net sales of $2.77 billion increased 5% from the $2.64 billion reported a year ago. Foreign exchange rate movement had no impact on the quarterly sales growth rate.

1 Feb 2011

Roundup: Tenn. community health centers feel budget pinch; Minn. faces struggles with costs of inmate care

Originally created to care for destitute urban dwellers or dirt-poor sharecroppers, health centers today serve a much wider segment of America. A prolonged recession and a shortage of primary care physicians have expanded their patient base. Going forward, they are expected to meet the needs of millions more Americans. But getting there could be a challenge.

1 Feb 2011

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that it has received approval from Health Canada for the Acculis Accu2i percutaneous microwave tissue ablation system for the coagulation of soft tissue during surgical procedures.

1 Feb 2011

Cappella initiates multi-center Italian Sideguard open label clinical study

Cappella Medical Devices announces initiation of the multi-center Italian Sideguard® open label clinical study. The Principal Investigator (PI) of the study, Dr. Giuseppe Massimo Sangiorgi at the Policlinico di Modena - University of Modena and Reggio Emilia, in Modena, Italy stated, "The side branch ostium anatomy requires a unique technology solution to effectively manage and optimize treatment.

1 Feb 2011

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Encision, a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its third fiscal quarter ended December 31, 2010.

31 Jan 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces the commercial availability in Europe of the self- anchoring Perceval S aortic heart valve. The innovative next-generation valve represents the latest innovation in heart valve technology.

31 Jan 2011

Angiotech commences CCAA proceedings to implement pre-packaged financial restructuring

Angiotech Pharmaceuticals, Inc. today announced that, further to its news release issued earlier today, the Company and certain of its subsidiaries have voluntarily commenced proceedings under the Companies' Creditors Arrangement Act in order to continue implementation of its previously announced recapitalization transaction, having obtained an Initial Order from the Supreme Court of British Columbia today.

29 Jan 2011

Medical Devices News and Research

Smartphone juggernaut will impact revenues, design strategies, and IP management, say UBM TechInsights

Misonix completes product registrations in major Latin American countries

Law allowing use of unproven brain devices in "orphan" neuropsychiatric disorders needs to be strengthened: Experts

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

Helix Medical to invest over $4M for new manufacturing facility in Costa Rica

Patient need to share medication side effects with health care team: Retired family doctor

Free web-based networking solution for health care professionals to be presented at AAD meeting

Microsulis' Microwave Endometrial Ablation platform sold to Hologic

Roundup: House Republicans plan to advance anti-abortion agenda with action next week; Medical device makers lobby to repeal tax

More careful regulation of FDA's Humanitarian Device Exemption in psychiatric patients needed

Positive results from Derma Sciences' Phase 2 trial with DSC127 in patients with diabetic foot ulcers

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

Kensey Nash second quarter revenue decreases to $17.4 million

Covidien first-quarter net sales increase 5% to $2.77 billion

Roundup: Tenn. community health centers feel budget pinch; Minn. faces struggles with costs of inmate care

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Cappella initiates multi-center Italian Sideguard open label clinical study

Encision reports gross profit margin increase in third quarter of fiscal year 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Angiotech commences CCAA proceedings to implement pre-packaged financial restructuring

Industry Focus eBook - Medical Devices (3rd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News